EMPYREAN NEUROSCIENCE
A Novel Approach to Neuropsychiatry and Neurology
Genetic engineering
for the neuroscience revolution.
Depression and anxiety are the leading cause of disability worldwide, affecting up to 300 million people and they are associated with the loss of 10 years life expectancy.
Empyrean Neuroscience is developing first-in-class, neuroactive therapeutics using genetic engineering to improve the lives of patients suffering from debilitating neuropsychiatric and neurologic disorders.
Bringing the “fun” to fungi... 🤦♂️
Bad puns aside, we teamed up with MacDougall Advisors to help tell the story of how Empyrean’s genetic engineering platform unlocks the therapeutic power of plants and fungi.
We developed an engaging 3D animation that details the “entourage effect”, a cascade of small molecules inherent to plants and fungi that work in concert to generate positive patient experiences and health benefits.
Style Frames
Final Result
The animation we produced successfully addresses both patient and provider audiences, and showcases the benefits Empyrean’s platform enables for people suffering from depression and anxiety.
Let’s Get Started.
Want to discuss your next project, or just get some further information? We'd love to chat.